Homepage
Catalog of Screening Compounds Screening Libraries Focused and Target Libraries Active Reference Sets Diversity Libraries
Screening Compounds Building blocks
Drug Discovery Services Custom Chemistry Medicinal chemistry In silico Drug Design (CADD) Discovery Biology Animal Models Toxicology and Safety ADME, DMPK Chemistry, Manufacturing and Controls
Company News & Media Contact us For suppliers Trends in discovery compounds
Homepage > Company > Media > Pharma News > 2015

Pharma News, 2015

FDA approves Adapt Pharma’s naloxone nasal spray
FDA approves Adapt Pharma’s naloxone nasal spray
SILVER SPRING, Md.
U.S. doctor group calls for ban on drug advertising to consumers
U.S. doctor group calls for ban on drug advertising to consumers
The American Medical Association on Tuesday called for a ban on advertising prescription drugs and medical devices directly to consumers, saying the ads drive patients to demand expensive treatments o...
Senators grilled Obama's nominee for FDA chief. Here's how he responded
Senators grilled Obama's nominee for FDA chief. Here's how he responded
President Obama's nominee for FDA commissioner was grilled Tuesday by members of the Senate committee on Health, Education, Labor and Pensions on issues ranging from the controversy over drug pric...
Alzheimer’s drug surprises researchers, reverses aging in mice
Alzheimer’s drug surprises researchers, reverses aging in mice
Researchers with the Salk Institute of Biological Studies stumbled across unexpected anti-aging effects when working with an experimental Alzheimer’s treatment drug called J147.
FDA approves Darzalex for patients with previously treated multiple myeloma
FDA approves Darzalex for patients with previously treated multiple myeloma
Today the U.
Pharma Industry Veterans Launch Vertice Pharma in Partnership with Warburg Pincus; Announce Acquisition of VistaPharm
Pharma Industry Veterans Launch Vertice Pharma in Partnership with Warburg Pincus; Announce Acquisition of VistaPharm
NEW YORK, Nov.
Drug that could limit spread of deadly brain tumours
Drug that could limit spread of deadly brain tumours
New York.
A New Therapeutic Approach Treats Alzheimer's Disease With Photoactive Chemicals
A New Therapeutic Approach Treats Alzheimer's Disease With Photoactive Chemicals
Photoactive chemicals may provide a therapeutic strategy in the treatment of neurodegenerative diseases, according to a recent study.
FDA approves new pill to treat certain patients with non-small cell lung cancer
FDA approves new pill to treat certain patients with non-small cell lung cancer
Today, the U.
Swissmedic approves Xadago to treat Parkinson’s Disease
Swissmedic approves Xadago to treat Parkinson’s Disease
The Swiss Agency for Therapeutic Products (Swissmedic) has approved Xadago (safinamide) for use in Parkinson’s Disease (PD).
Roche Gets FDA Approval for New Advanced Melanoma Treatment
Roche Gets FDA Approval for New Advanced Melanoma Treatment
Roche announced that the U.
FDA Gives Breakthrough Designation to Teva's Tardive Dyskinesia Drug
FDA Gives Breakthrough Designation to Teva's Tardive Dyskinesia Drug
Teva announced that the U.
Catalog of Screening Compounds Screening Libraries Screening Compounds Building blocks
Drug Discovery Services News & Media Contact us
Payment systems
Policies & Terms     ©2023 ChemDiv     ChemistryOnDemand